5,0
15 apr 2015
Dipendente anonimo
Dipendente attuale, più di 3 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Jay has done a great job of turning around the company from where it was before he came. There have been departures at the executive level which may look bad to investors, but the change has been positive. New management are driving towards a more strategic, innovative culture that will produce results. It's a different strategy, that should attract a different class of investor.
Svantaggi
We need more people in the company who have a background in surgical medical device product development. We need to work more closely with surgeons during product development. We need to improve our reputation with investors/industry.